Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
14.38
-1.47 (-9.27%)
At close: Jun 5, 2026, 4:00 PM EDT
14.27
-0.11 (-0.77%)
After-hours: Jun 5, 2026, 7:58 PM EDT
| Period Ending | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Software Products and Services | 186.24M | 199.50M | 209.92M | 200.94M | 195.80M | 180.40M | 169.40M | 166.42M | ||||||
| Software Products and Services Growth | -4.88% | 10.59% | 23.92% | 20.74% | 22.09% | 13.34% | 22.52% | 24.17% | ||||||
| Drug Discovery | 68.66M | 56.37M | 47.12M | 37.06M | 34.77M | 27.22M | 24.02M | 34.28M | ||||||
| Drug Discovery Growth | 97.47% | 107.09% | 96.16% | 8.10% | 23.37% | -52.72% | -60.67% | -42.60% |
| Period Ending | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Software Products and Services | 26.88M | 27.51M | 27.26M | ||||||||||||||
| Software Products and Services Growth | -2.04% | 1.09% | 0.40% | ||||||||||||||
| Software Contribution | 12.14M | 15.99M | 18.18M | 16.37M | 11.86M | 8.02M | 3.12M | 1.80M | - | - | - | ||||||
| Software Contribution Growth | 2.39% | 99.45% | 481.91% | 809.61% | 558.89% | 345.33% | 73.56% | - | - | - | - | ||||||
| Drug Discovery | 11.71M | 12.98M | 7.15M | ||||||||||||||
| Drug Discovery Growth | 8.73% | 63.40% | -16.15% |
| Period Ending | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Discovery Services Customer Contracts | 67.40M | 54.76M | 45.32M | 35.12M | 32.69M | 25.14M | 21.97M | 31.88M | ||||||
| Drug Discovery Services Customer Contracts Growth | 106.21% | 117.79% | 106.30% | 10.16% | 27.64% | -54.05% | -62.27% | -44.26% | ||||||
| Drug Discovery Contribution | 1.26M | 1.61M | 1.76M | 1.89M | 2.04M | 2.03M | 2.02M | 2.37M | ||||||
| Drug Discovery Contribution Growth | -38.30% | -20.78% | -13.29% | -20.12% | -19.95% | -28.03% | -29.72% | -6.89% |
| Period Ending | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | 154.71M | 152.96M | 131.30M | 124.59M | 121.24M | 114.87M | 133.14M | 141.65M | ||||||
| United States Growth | 27.61% | 33.16% | -1.39% | -12.05% | -10.14% | -29.08% | -8.89% | 0.83% | ||||||
| EMEA | 72.25M | 75.16M | 91.28M | 80.70M | 81.54M | 65.65M | 33.86M | 32.48M | ||||||
| EMEA Growth | -11.39% | 14.49% | 169.56% | 148.50% | 176.37% | 125.33% | 22.28% | 14.51% | ||||||
| APAC | 26.78M | 26.18M | 32.70M | 31.23M | 26.38M | 25.80M | 25.18M | 25.47M | ||||||
| APAC Growth | 1.54% | 1.47% | 29.87% | 22.62% | 14.69% | 5.02% | -19.14% | -16.40% | ||||||
| Rest of World | 1.16M | 1.56M | 1.67M | 1.40M | 1.35M | 1.22M | 1.16M | 1.03M | ||||||
| Rest of World Growth | -13.53% | 28.16% | 44.18% | 35.43% | 25.94% | 21.68% | - | - |